MARK W. LEDEBOER,MICHAEL P. CLARK,UPUL K. BANDARAGE,RANDY S. BETHIEL,HONGBO DENG,JOHN P. DUFFY,HUAI GAO,PAUL S. CHARIFSON,MICHAEL J. BOYD,IOANA DAVIES,LUC J. FARMER,WENXIN GU,BRIAN LEDFORD,FRANCOIS MA
申请号：
PT12746215
公开号：
PT2739623T
申请日:
2012.08.01
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula ( I ): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A compound is represented by Structural Formula ( I ) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
